BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27009493)

  • 1. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation.
    Lee CW; Wohlan K; Dallmann I; Förster R; Ganser A; Krueger A; Scherr M; Eder M; Koenecke C
    J Immunol; 2016 May; 196(9):3927-34. PubMed ID: 27009493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
    Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
    Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.
    Zitzer NC; Snyder K; Meng X; Taylor PA; Efebera YA; Devine SM; Blazar BR; Garzon R; Ranganathan P
    J Immunol; 2018 Jun; 200(12):4170-4179. PubMed ID: 29720426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease.
    Xie L; Zhou F; Liu X; Fang Y; Yu Z; Song N; Kong F
    Cytokine; 2016 Sep; 85():37-44. PubMed ID: 27288630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
    Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.
    Ewing P; Hildebrandt GC; Planke S; Andreesen R; Holler E; Gerbitz A
    Int J Mol Med; 2007 Sep; 20(3):301-8. PubMed ID: 17671733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of bone marrow mesenchymal stem cells on acute graft versus host disease and graft versus leukemia after allogeneic bone marrow transplantation].
    Hu WB; Gao QP; Chen YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):404-7. PubMed ID: 15972130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.
    Li M; Sun K; Redelman D; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):739-50. PubMed ID: 20338256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of acute graft-versus-host disease by microRNA-155.
    Ranganathan P; Heaphy CE; Costinean S; Stauffer N; Na C; Hamadani M; Santhanam R; Mao C; Taylor PA; Sandhu S; He G; Shana'ah A; Nuovo GJ; Lagana A; Cascione L; Obad S; Broom O; Kauppinen S; Byrd JC; Caligiuri M; Perrotti D; Hadley GA; Marcucci G; Devine SM; Blazar BR; Croce CM; Garzon R
    Blood; 2012 May; 119(20):4786-97. PubMed ID: 22408260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
    Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetics of Infiltrating CD3
    Zhao K; Ruan SH; Tian Y; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):931-936. PubMed ID: 34105496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation.
    Li Z; Gu J; Liu J; Zhu Q; Lu H; Lu Y; Rao J; Lu L; Wang X
    Int Immunopharmacol; 2017 May; 46():201-209. PubMed ID: 28324830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease.
    Li B; New JY; Yap EH; Lu J; Chan SH; Hu H
    Eur J Immunol; 2001 Feb; 31(2):617-24. PubMed ID: 11180127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
    Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
    Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
    Luo X; Xu L; Li Y; Tan H
    Cell Biol Toxicol; 2017 Apr; 33(2):169-181. PubMed ID: 27770236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
    Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
    Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.